FedEx sues for refund of Trump tariffs, days after Supreme Court ruling

1 hour ago

Jamie Dimon says 'watch out' as lofty asset prices add to economic risks: 'My anxiety is high'

4 minutes ago

Dow drops 800 points as AI disruption fears and tariff woes weigh on markets: Live updates

4 hours ago

IBM is the latest AI casualty. Shares tank 13% on Anthropic programming language threat

4 hours ago

Eli Lilly launches new form of obesity drug Zepbound with a month's worth of doses in one pen

11 hours ago

Novo Nordisk down 15% after weight loss drug fails to match Eli Lilly's in trial

11 hours ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

4 days ago

Kennedy defends Trump glyphosate order as MAHA erupts

4 days ago

FDA chief calls for reforms as U.S. loses ground to China in early drug trials

4 days ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

5 days ago

FDA chief Marty Makary says more drugs should be available over the counter

5 days ago

Danaher is tapping the M&A well yet again. But we might have had enough

6 days ago

French prosecutors investigate Nestle, Danone over contaminated baby formula

6 days ago

Novo Nordisk faces a defining year in the obesity drug market

7 days ago

How largest health-care education company in U.S. is tackling growing jobs gap

12 days ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

12 days ago

Moderna says FDA refuses to review its application for experimental flu shot

13 days ago

CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold

13 days ago

Florida law models what genetic disease testing could be

13 days ago

FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims

13 days ago

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections

14 days ago

Hims & Hers stops offering weight loss pill after threats of legal action

14 days ago

Healthy Returns: Pfizer execs chart out obesity drug strategy

16 days ago

White House launches direct-to-consumer drug site TrumpRx. Here's what to know

18 days ago

Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline

18 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar

19 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

20 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

20 days ago

Merck tops quarterly estimates, posts modest outlook as generic competition looms

20 days ago

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

20 days ago

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

24 days ago

As ACA subsidies expire, health costs emerge as top economic worry for voters: survey

24 days ago

Breakthrough drug helps 11-year-old battle rare neurological gene mutation

24 days ago

Healthy Returns: 15 drugs added to Medicare price negotiations

24 days ago

Danaher stock fails to rise on solid earnings — leading us to question what's next

26 days ago

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

26 days ago

Next up in weight loss drugs: More pills, easier access and drug combinations

27 days ago

Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s

1 month ago